pMJ922 Citations (3)
Originally described in: Maximizing mutagenesis with solubilized CRISPR-Cas9 ribonucleoprotein complexes.Burger A, Lindsay H, Felker A, Hess C, Anders C, Chiavacci E, Zaugg J, Weber LM, Catena R, Jinek M, Robinson MD, Mosimann C Development. 2016 Apr 29. pii: dev.134809. PubMed Journal
Articles Citing pMJ922
Articles |
---|
A Rapid Method for Directed Gene Knockout for Screening in G0 Zebrafish. Wu RS, Lam II, Clay H, Duong DN, Deo RC, Coughlin SR. Dev Cell. 2018 Jul 2;46(1):112-125.e4. doi: 10.1016/j.devcel.2018.06.003. PubMed |
Impact of Formulation Conditions on Lipid Nanoparticle Characteristics and Functional Delivery of CRISPR RNP for Gene Knock-Out and Correction. Walther J, Wilbie D, Tissingh VSJ, Oktem M, van der Veen H, Lou B, Mastrobattista E. Pharmaceutics. 2022 Jan 17;14(1):213. doi: 10.3390/pharmaceutics14010213. PubMed |
A Robust Expression and Purification Method for Production of SpCas9-GFP-MBP Fusion Protein for In Vitro Applications. Fleitas AL, Senorale M, Vidal S. Methods Protoc. 2022 May 28;5(3). pii: mps5030044. doi: 10.3390/mps5030044. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.